September 22, 2022

Chromatography innovations for the diverse antibody pipeline

To support development of new therapeutic possibilities, manufacturing and process development technologies must also evolve. For antibody variants, platform purification protocols for conventional mAb aren’t always providing sufficient outputs — some variants need new ligands, new base matrices, or new chromatography systems, or they have different regulatory requirements, or application needs.

In this video Josefin Bolik, global product manager — antibody capture at Cytiva, presents how to select resins for your antibody variant purification project.


Tags: purification, Mab, capture, affinity, antibody variant, antibody, chromatography